Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Open
Phase 2/3
This trial is looking at a drug called BNT327 in combination with standard chemotherapy.
It is for people whose non small cell lung cancer has spread and they:
are having their first treatment for advanced non small cell lung cancer
can’t have surgery or radiotherapy with the aim to cure
Recruitment start: 28 February 2025
Recruitment end: 31 May 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Yvonne Summers
BioNTech SE
Last reviewed: 14 Apr 2025
CRUK internal database number: 20018
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
